Investments  

New year ushers in growth opportunities for biotech firms

New year ushers in growth opportunities for biotech firms

All major global equity indices declined in 2018, due to fears of a global economic slowdown associated with US-China trade disputes and concern about tightening US fiscal policy. 

The content you are trying to access is only available to users with an FTAdviser.com subscription

Subscribe to FTAdviser now for:

- Full access to articles written by the Money Management team

- No limit to the number of articles you can read every month

- The ability to use Money Management's uniquely prepared fund statistics - on the web, or by downloading a pdf

Unlock unlimited articles
Subscribe